{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 9.6, "regularMarketPrice": 1.37, "exchange": "NCM", "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1026826200000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.120000005, "regularMarketTime": 1684180795, "regularMarketDayHigh": 1.38, "regularMarketDayRange": "1.29 - 1.38", "regularMarketDayLow": 1.29, "regularMarketVolume": 42091, "regularMarketPreviousClose": 1.25, "bid": 0.0, "ask": 0.0, "bidSize": 14, "askSize": 14, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 1.29, "averageDailyVolume3Month": 145878, "averageDailyVolume10Day": 217020, "fiftyTwoWeekLowChange": 0.7, "fiftyTwoWeekLowChangePercent": 1.0447761, "fiftyTwoWeekRange": "0.67 - 6.6", "fiftyTwoWeekHighChange": -5.23, "fiftyTwoWeekHighChangePercent": -0.79242426, "fiftyTwoWeekLow": 0.67, "fiftyTwoWeekHigh": 6.6, "dividendDate": 1473984000, "earningsTimestamp": 1679487015, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.39, "epsForward": -3.4, "epsCurrentYear": -3.4, "priceEpsCurrentYear": -0.40294117, "sharesOutstanding": 8798830, "bookValue": 2.332, "fiftyDayAverage": 1.2496, "fiftyDayAverageChange": 0.12039995, "fiftyDayAverageChangePercent": 0.09635079, "twoHundredDayAverage": 2.8328, "twoHundredDayAverageChange": -1.4627999, "twoHundredDayAverageChangePercent": -0.51637954, "marketCap": 13648474, "forwardPE": -0.40294117, "priceToBook": 0.5874786, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "displayName": "Marker Therapeutics", "symbol": "MRKR"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4551 Kennedy Commerce Drive", "city": "Houston", "state": "TX", "zip": "77032", "country": "United States", "phone": "713-400-6400", "website": "https://www.markertherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML) and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing MT-401, which is in Phase 2 clinical trial for the treatment of post-transplant AML; MT-401-OTS for the treatment of AML; and MT-601 for the treatment of pancreatic cancer and lymphoma. Marker Therapeutics was founded in 1999 and is headquartered in Houston, Texas.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 42, "title": "Co-Founder, CEO, Pres & Director", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 529123, "fmt": "529.12k", "longFmt": "529,123"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael J. Loiacono", "age": 56, "title": "Chief Accounting Officer, Treasurer & Sec.", "yearBorn": 1966, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Admin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nadia  Agopyan Ph.D.", "title": "Sr. VP of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Monic  Stuart", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr.", "title": "Sr. Director of Molecular Biology & Virology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}